Abstract
We analyzed four cases of systemic lupus erythematosus (SLE) with chylous pleural effusion treated in our hospital from June 2013 to May 2017. The three females and one male ranged in age from 22 to 33 years. The length of disease course was 20 to 120 months. Treatment with glucocorticoids and immunosuppressants (cyclophosphamide or cyclosporine A) did not reduce chylous pleural effusion. Lymphatic obstruction was found in all patients after direct lymphangiography and the pleural effusion was significantly reduced after surgery. A literature search identified six previously reported patients with SLE and chylous pleural effusion. Five were sensitive to classic immunosuppression treatment, probably due to early intervention. However, as shown here, the thoracic duct can be involved in SLE, leading to an intractable chylous pleural effusion with no response to medical treatment. Surgery would be a better choice when lymphatic mechanical obstruction is found.
Zusammenfassung
Die Autoren werteten 4 Fälle von systemischem Lupus erythematodes (SLE) mit chylösem Pleuraerguss aus, die zwischen Juni 2013 und Mai 2017 in der Klinik der Autoren behandelt worden waren. Die Patienten (3 w., 1 m.) waren zwischen 22 und 33 Jahre alt. Die Dauer des Krankheitsverlaufs betrug 20–120 Monate. Durch Behandlung mit Glukokortikoiden und Immunsuppressiva (Cyclophosphamid oder Ciclosporin) verminderte sich der chylöse Pleuraerguss nicht. In der direkten Lymphangiographie wurden bei allen Patienten lymphatische Obstruktionen festgestellt, nach operativer Therapie war der Pleuraerguss jeweils signifikant reduziert. Eine Literaturrecherche ergab 6 bereits dokumentierte Fälle von Patienten mit SLE und chylösem Pleuraerguss. Fünf sprachen auf eine klassische Immunsuppressionstherapie an, wahrscheinlich aufgrund einer frühzeitigen Intervention. Wie hier gezeigt, kann der Ductus thoracicus jedoch bei SLE mitbetroffen sein, und es kann zu einem hartnäckigen chylösen Pleuraerguss ohne Ansprechen auf eine medikamentöse Behandlung kommen. Bei Vorliegen einer lymphatischen mechanischen Obstruktion stellt eine Operation daher die bessere Wahl dar.
Similar content being viewed by others
References
Rahman A, Isenberg DA (2008) Systemic lupus erythematosus. N Engl J Med 358(9):929–939
Zhao J, Bai W, Zhu P, Zhang X, Liu S, Wu L et al (2016) Chinese SLE Treatment and Research group CSTAR registry VII: prevalence and clinical significance of serositis in Chinese patients with systemic lupus erytbematosus. Lupus 25(6):652–657
Hocherg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725
SteinDoerr CH, Allen MS, Nichols FC, Ryu JH (2005) Etiology of chylothorax in 203 patients. Mayo Clin Proc 80:867–870
Soto-Martinez M, Massie J (2009) Chylothorax: diagnosis and management in children. Paediatr Respir Rev 10:199–207
Steinemann DC, Dindo D, Clavien PA, Clavien PA, Nocito A (2011) Atraumatic chylous ascites:systematic review on symptoms and causes. J Am Coll Surg 212(5):899–905
Lee CK, Han JM, Lee KN, Lee EY, Shin JH, Cho YS et al (2002) Concurrent occurrence of chylothorax, chylous ascites, and protein-losing enteropathy in systemic lupus erythematosus. J Rheumatol 29:1330–1337
Lin YJ, Chen Yj LJL, Hsieh TY (2007) Chylothorax as the initial presentation of systemic lupus erythematosus: a case report. Clin Rheumatol 26:1373–1374
Manzella DJ, Dettori PN, Hertimian ML, Melero MJ (2013) Chylous ascitesand ehylothorax as presentation of a systemic progression of discoid lupus. J Clin Rheumatol 19:87–89
Soysal DE, Hizar Turan S, Ozmen M, Pekdiker M, Kalender ME, Koc E et al (2013) A rare case of systemic lupus erythematosus with chylous ascites and chylothorax. Case Rep Rheumatol 2013:797696
Narita Y, Naoki K, Hida N, Okamoto H, Kunikane H, Omori T et al (2008) Case of bilateral chylothorax with systemic lupus erythematosus complicated by steroid-/immunosuppressant-resistant pleural effusion. Nihon Kokyuki Gakkai Zasshi 46(2):120–125
Ocampo V, Haaland D, Legault K, Mittoo S, Aitken E (2016) Successful treatment of recurrent pleural and pericardial effusions with tocilizumab in a patient with systemic lupus erythematous. BMJ Case Rep 8:2016
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
P. Song, J. Zhang, C. Shang, and L. Zhang declare that they have no competing interests.
This article does not contain any studies with human participants or animals performed by any of the authors.
Additional information
Redaktion
U. Müller-Ladner, Bad Nauheim
U. Lange, Bad Nauheim
Rights and permissions
About this article
Cite this article
Song, P., Zhang, J., Shang, C. et al. Refractory chylous pleural effusion with systemic lupus erythematosus. Z Rheumatol 78, 797–802 (2019). https://doi.org/10.1007/s00393-018-0545-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00393-018-0545-z